Stem Cell Transplantation for Chronic Myeloid Leukemia (CML): Current Indications and Perspectives

By  

Current Cancer Drug Targets, Vol. 13, Iss. 7, 2013-01 ,pp. : 775-778

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Anti-leukemic Therapy as Disease-stabilizing Treatment for Acute Myeloid Leukemia Relapse after Allogeneic Stem Cell Transplantation: Will it be Possible to Combine these Strategies with Retransplantation or Donor Lymphocyte Infusions?

By  

Current Cancer Drug Targets, Vol. 13, Iss. 1, 2013-01 ,pp. : 30-47

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Pathogenesis of Philadelphia-Positive Chronic Myeloid Leukemia - is it all BCR-ABL?

By  

Current Cancer Drug Targets, Vol. 11, Iss. 1, 2011-01 ,pp. : 3-19

Bentham Science Publishers

Access to resources Recommend Favorite

Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or Philadelphia chromosome–positive acute lymphoblastic leukemia

By Shimoni Avichai   Volchek Yulia   Koren-Michowitz Maya   Varda-Bloom Nira   Somech Raz   Shem-Tov Noga   Yerushalmi Ronit   Nagler Arnon  

Cancer, Vol. 121, Iss. 6, 2015-03 ,pp. : 863-871

Blackwell Publishing

Access to resources Recommend Favorite

A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor

By  

Current Cancer Drug Targets, Vol. 15, Iss. 6, 2015-01 ,pp. : 493-503

Bentham Science Publishers

Access to resources Recommend Favorite